Literature DB >> 16855767

Testosterone decreases adiponectin levels in female to male transsexuals.

Marta Berra1, Francesca Armillotta, Laura D'Emidio, Antonietta Costantino, Giuseppe Martorana, Giuseppe Pelusi, Maria Cristina Meriggiola.   

Abstract

AIM: To evaluate the effect of testosterone (T) on adiponectin serum levels in transsexual female patients.
METHODS: We measured adiponectin, leptin, luteinizing hormone and follicle stimulating hormone, T, estradiol, lipid profile, biochemical parameters and body composition in 16 transsexual female patients at baseline and after 6 months of T treatment (100 mg Testoviron Depot /10 days, i.m.).
RESULTS: Adiponectin levels were 16.9 +/- 7.3 mg/mL at baseline and 13.5 +/- 7.4 mg/mL at month 6 of T treatment (P < 0.05). Leptin and high-density lipoprotein cholesterol decreased significantly, whereas body mass index, waist circumference and lean body mass increased significantly after 6 months of T treatment. No changes in insulin or Homeostasis Model Assessment were detected.
CONCLUSION: T can significantly reduce adiponectin serum levels in transsexual female patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855767     DOI: 10.1111/j.1745-7262.2006.00204.x

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  14 in total

1.  Metabolic disorders in newly diagnosed young adult female patients with simple virilizing 21-hydroxylase deficiency.

Authors:  Hui-Jie Zhang; Jun Yang; Man-Na Zhang; Chang-Qin Liu; Min Xu; Xue-Jun Li; Shu-Yu Yang; Xiao-Ying Li
Journal:  Endocrine       Date:  2010-10-27       Impact factor: 3.633

Review 2.  Systemic adiponectin malfunction as a risk factor for cardiovascular disease.

Authors:  Wayne Bond Lau; Ling Tao; Yajing Wang; Rong Li; Xin L Ma
Journal:  Antioxid Redox Signal       Date:  2011-04-20       Impact factor: 8.401

3.  Long-term cross-sex hormone treatment is safe in transsexual subjects.

Authors:  Maria Cristina Meriggiola; Marta Berra
Journal:  Asian J Androl       Date:  2012-08-27       Impact factor: 3.285

4.  Relationships of total adiponectin and molecular weight fractions of adiponectin with free testosterone in African men and premenopausal women.

Authors:  Jie Cui; XiangDong Wu; Jocelyn Andrel; Bonita Falkner
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11-15       Impact factor: 3.738

Review 5.  Contraception across transgender.

Authors:  Ilaria Mancini; Stefania Alvisi; Giulia Gava; Renato Seracchioli; Maria Cristina Meriggiola
Journal:  Int J Impot Res       Date:  2021-02-08       Impact factor: 2.896

6.  SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people.

Authors:  A D Fisher; G Senofonte; C Cocchetti; G Guercio; V Lingiardi; M C Meriggiola; M Mosconi; G Motta; J Ristori; A M Speranza; M Pierdominici; M Maggi; G Corona; F Lombardo
Journal:  J Endocrinol Invest       Date:  2021-10-22       Impact factor: 4.256

7.  Alterations in Lipids and Adipocyte Hormones in Female-to-Male Transsexuals.

Authors:  Prakash Chandra; Sukhdeep S Basra; Tai C Chen; Vin Tangpricha
Journal:  Int J Endocrinol       Date:  2010-07-18       Impact factor: 3.257

8.  Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study.

Authors:  Hua Ling; Dawn M Waterworth; Heide A Stirnadel; Toni I Pollin; Philip J Barter; Y Antero Kesäniemi; Robert W Mahley; Ruth McPherson; Gérard Waeber; Thomas P Bersot; Jonathan C Cohen; Scott M Grundy; Vincent E Mooser; Braxton D Mitchell
Journal:  Obesity (Silver Spring)       Date:  2009-01-22       Impact factor: 5.002

9.  Influence of androgens on circulating adiponectin in male and female rodents.

Authors:  Joshua F Yarrow; Luke A Beggs; Christine F Conover; Sean C McCoy; Darren T Beck; Stephen E Borst
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

Review 10.  Gynaecological aspects of the treatment and follow-up of transsexual men and women.

Authors:  S Weyers; P De Sutter; S Hoebeke; G Monstrey; G 'T Sjoen; H Verstraelen; J Gerris
Journal:  Facts Views Vis Obgyn       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.